https://www.nasdaq.com/press-release/aziyo-biologics-to-present-at-the-h.c.-wainwright-bioconnect-virtual-conference-2021
https://www.nasdaq.com/press-release/aziyo-biologics-announces-%2414.0-million-private-placement-2021-12-06
https://www.nasdaq.com/press-release/aziyo-biologics-to-participate-in-upcoming-virtual-investor-conferences-2021-11-15
https://www.nasdaq.com/press-release/aziyo-biologics-reports-third-quarter-2021-financial-results-2021-11-09
https://www.nasdaq.com/press-release/aziyo-biologics-provides-business-update-and-preliminary-third-quarter-2021-revenue
https://www.nasdaq.com/press-release/aziyo-biologics-to-participate-in-the-2021-cantor-global-healthcare-conference-2021
https://www.nasdaq.com/press-release/aziyo-biologics-appoints-peter-g.-edwards-as-general-counsel-2021-08-31
https://www.nasdaq.com/press-release/aziyo-biologics-reports-second-quarter-2021-financial-results-2021-08-09
https://www.nasdaq.com/press-release/aziyo-biologics-to-report-second-quarter-2021-financial-results-on-monday-august-9
https://www.nasdaq.com/press-release/aziyo-biologics-comments-on-june-2nd-voluntary-recall-of-one-lot-of-its-fibercel
https://www.nasdaq.com/press-release/aziyo-biologics-reports-first-quarter-2021-financial-results-and-increases-2021
https://www.nasdaq.com/press-release/aziyo-biologics-announces-initiation-of-de-novo-cangaroo-clinical-study-2021-04-28
https://www.nasdaq.com/press-release/aziyo-biologics-to-participate-in-the-truist-securities-life-sciences-summit-2021-04
https://www.nasdaq.com/press-release/aziyo-biologics-to-report-first-quarter-2021-financial-results-on-tuesday-may-4-2021
https://www.nasdaq.com/press-release/aziyo-biologics-reports-fourth-quarter-and-full-year-2020-financial-results-2021-03
https://www.nasdaq.com/press-release/aziyo-biologics-to-participate-in-the-cowen-41st-annual-health-care-conference-2021
https://www.nasdaq.com/press-release/aziyo-biologics-announces-first-patient-enrolled-in-heal-study-2021-02-17
https://www.nasdaq.com/press-release/aziyo-biologics-to-report-fourth-quarter-and-full-year-2020-financial-results-on
https://www.nasdaq.com/press-release/aziyo-biologics-announces-product-design-completion-for-its-next-generation-cangaroor
https://www.nasdaq.com/press-release/aziyo-biologics-announces-updated-cangaroor-envelope-label-in-european-markets-to
https://www.nasdaq.com/press-release/aziyo-biologics-reports-third-quarter-2020-financial-results-2020-11-19
https://www.nasdaq.com/press-release/aziyo-biologics-to-participate-in-the-piper-32nd-annual-virtual-healthcare-conference
https://www.nasdaq.com/press-release/surgalign-holdings-and-aziyo-biologics-announce-expanded-distribution-agreement-2020
https://www.nasdaq.com/press-release/aziyo-biologics-awarded-breakthrough-technology-contract-with-premier-inc.-2020-11-12
